As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...